InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,868.40
(
-0.79%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.01
(
-0.25%
)
Bitcoin
64,464.00
(
0.28%
)
Post# of 13874
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Iam_in

Send PM Follow Ignore
Followers 2
Posts 266
Boards Moderated 0
Alias Born 08/12/2016

Iam_in

Re: None

Thursday, 06/29/2017 7:59:09 AM

Thursday, June 29, 2017 7:59:09 AM

Post# of 13874
Finally some NEWS about the Pint deal

Immune Pharmaceuticals' Oncology Subsidiary, Cytovia Inc. Provides Update to Proposed Pint Pharma Transaction: Substantial Agreement Reached on Material Terms of the Licensing and Commercialization of Ceplene® in Latin America

complete text:

https://www.bequoted.com/bolag/immune-pharmaceuticals/pressmeddelande/immune-pharmaceuticals-oncology-subsidiary-cytovia-inc-provi-59445
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up